Henan Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 87,000,000 in its equity round of funding from returning investor, Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. on June 13, 2024. The investor will continue to hold 100% stake in the company. The registered capital of the company will increase from CNY 18,000,000 to CNY 105,000,000 upon closing.

The transaction has been reviewed and approved in the 6th extraordinary meeting of the 6th board of directors of the returning investor.